Journal
/
/
The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
JoVE Journal
Chemistry
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Chemistry
The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
DOI:

09:29 min

February 12, 2015

,

Chapters

  • 00:05Title
  • 01:15Conjugation of DFO-NCS to J591
  • 02:56Radiolabeling J591-DFO with 89Zr
  • 06:16In Vivo PET Imaging with 89Zr-DFO-J591
  • 07:52Results: PET Imaging with 89Zr-DFO-J591
  • 09:03Conclusion

Summary

Automatic Translation

Due to its multi-day radioactive half-life and favorable decay properties, the positron-emitting radiometal 89Zr is extremely well-suited for use in antibody-based radiopharmaceuticals for PET imaging. In this protocol, the bioconjugation, radiosynthesis, and preclinical application of 89Zr-labeled antibodies will be described.

Related Videos

Read Article